导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 603259 | 药明康德 | 4.53% | 6.71% | 0.3040% |
| 600276 | 恒瑞医药 | 4.39% | 1.63% | 0.0716% |
| 002821 | 凯莱英 | 4.00% | 3.99% | 0.1596% |
| 688221 | 前沿生物-U | 3.97% | 2.66% | 0.1056% |
| 688046 | 药康生物 | 3.90% | 6.37% | 0.2484% |
| 688428 | 诺诚健华 | 3.74% | 6.21% | 0.2323% |
| 688197 | 首药控股-U | 3.45% | 5.01% | 0.1728% |
| 301096 | 百诚医药 | 3.36% | 2.04% | 0.0685% |
| 688180 | 君实生物-U | 3.28% | 6.14% | 0.2014% |
| 603127 | 昭衍新药 | 3.27% | 1.77% | 0.0579% |
| 重仓股合计:37.89%, 重仓股贡献增长率: 1.6221%, 总持股仓位:94.37%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2026-09-16 | 1.09% | 3.19% |
| 2026-09-15 | -0.79% | 3.19% |
| 2026-09-14 | 2.96% | 3.19% |
| 2026-09-11 | -1.67% | 3.19% |
| 2026-09-10 | -1.53% | 3.19% |
| 2026-09-09 | -1.22% | 3.19% |
| 2026-09-08 | 0.43% | 3.19% |
| 2026-09-07 | -0.64% | 3.19% |
| 基金名称 | 单位净值 | 增长率 |
| 长信创新驱动股票 | 2.5902 | 3.3582% |
| 长信企业成长三年持有混合A | 0.9695 | 2.6085% |
| 长信企业成长三年持有混合C | 0.9517 | 2.6085% |
| 长信中证科创创业50指数增强A | 1.6734 | 2.0592% |
| 长信中证科创创业50指数增强C | 1.6505 | 2.0592% |
| 长信利信混合A | 1.5821 | 1.7416% |
| 长信电子信息量化灵活配置混合A | 1.7750 | 1.6032% |
| 长信双利优选混合A | 1.7537 | 1.3403% |
| 长信利泰灵活配置混合A | 1.3587 | 1.0601% |
| 长信量化先锋混合A | 2.0568 | 1.0200% |
| 基金名称 | 单位净值 | 增长率 |
| 广发新兴成长混合C | 1.7912 | 5.2284% |
| 易方达瑞享混合I | 7.7336 | 4.9934% |
| 易方达瑞享混合E | 6.2573 | 4.9934% |
| 广发新兴成长混合A | 1.8177 | 4.7917% |
| 红土转型精选混合(LOF) | 4.8500 | 4.5477% |
| 红土精选混合C | 4.8469 | 4.5421% |
| 财通多策略福鑫定开混合 | 4.9368 | 4.4177% |
| 宏利成长混合 | 4.5907 | 4.4097% |
| 财通成长优选混合A | 4.2674 | 4.3878% |
| 财通成长优选混合C | 2.4510 | 4.3878% |
